First case report of perioperative management in a novel entity of macrothrombocytopenia: the autosomal dominant macrothrombocytopenia with platelet dysfunction associated with reduction of surface αIIbβ3
Author(s) -
Francisca Tavares,
Susana Domingues,
Ana Cristina Pires,
Carla Cavaleiro
Publication year - 2020
Publication title -
journal of clinical review and case reports
Language(s) - English
Resource type - Journals
ISSN - 2573-9565
DOI - 10.33140/jcrc.05.09.02
Subject(s) - desmopressin , tranexamic acid , medicine , aminocaproic acid , platelet , perioperative , platelet disorder , glanzmann's thrombasthenia , thrombasthenia , anesthesia , surgery , pediatrics , platelet aggregation , blood loss
Autosomal dominant macrothrombocytopenia with platelet dysfunction associated with reduction of surface αIIbβ3 (ADM) is an autosomal dominant form of Glanzmann’s thrombasthenia reported in few families in the literature. This case presents the first report of perioperative approach of a patient with ADM successfully submitted to a surgical procedure. The multidisciplinary approach including immunohaemotherapy consultation was considered the best clinical approach to avoid bleeding. The use of desmopressin and tranexamic acid in the preoperative period followed by desmopressin plus aminocaproic acid in the postoperative period showed to be safe and effective in the perioperative approach of the patient with ADM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom